Human herpesvirus types 6 and 7 infection in pediatric hematopoietic stem cell transplant recipients

Human herpesvirus types 6 and 7 infection in pediatric hematopoietic stem cell transplant recipients
复制标题

DOI:
10.12659/aot.889995
复制
发表时间:
2014-06-02
影响因子:
1.1
通讯作者:
Chan, Godfrey Chi Fung
Chan, Godfrey Chi Fung
中科院分区:
医学4区
文献类型:
--
作者:
Robles, Joseph Delano Fule;Cheuk, Daniel Ka Leung;Chan, Godfrey Chi Fung

文献摘要

被引文献

相似文献

背景:接受造血干细胞移植 (HSCT) 的患者处于免疫抑制状态,容易激活潜伏病毒感染,例如 6 型和 7 型疱疹病毒(HHV6 和 HHV7)。我们旨在评估儿科造血干细胞移植后 HHV6 和 HHV7 感染的发生率、表现、结果和危险因素。 材料/方法:2006 年至 2012 年期间,我们对 94 名儿童(56 名男孩,中位年龄 7.1 岁)进行了 106 例 HSCT(86 例同种异体和 20 例自体)。对疑似 HHV6 或 HHV7 感染的患者使用血清和/或脑脊液进行聚合酶链反应检测。 结果:在 63 名接受 HHV 检测的患者中,10 名患者 (15.9%) 在 HSCT 后平均 18 天感染(HHV-6 (n=6)、HHV-7 (n=4))(1 年累积发病率为 11.5%)。表现包括发烧(90%)、皮疹(70%)、肝炎(80%)、肺炎(50%)、中枢神经系统(CNS)表现(40%)和移植失败(10%)。尽管使用膦甲酸、更昔洛韦和西多福韦治疗,一名患者仍出现持续性中枢神经系统感染。平均 22 天后,7 名患者清除了疱疹病毒。 4 名患者死亡(恶性肿瘤复发 [n=3]、急性移植物抗宿主病 [aGVHD] [n=1])。疱疹病毒感染与腺病毒感染 (p=0.001) 和严重(III-IV 级)aGVHD (p=0.037) 相关。结论:我们得出结论,HHV6 和 HHV7 感染在儿科 HSCT 后很常见。大多数感染是自限性的,可能与腺病毒感染和严重的aGVHD有关。需要进一步的研究来评估严重发病率或死亡率的预测因素,并确定最佳的预防和治疗。
Background: The immunosuppressed state in patients undergoing hematopoietic stem cell transplantation (HSCT) predisposes them to activation of latent viral infections such as herpesvirus types 6 and 7 (HHV6 and HHV7). We aimed to evaluate the incidence, manifestations, outcomes, and risk factors of HHV6 and HHV7 infections after pediatric hematopoietic stem cell transplantation.Material/Methods: We performed 106 HSCTs (86 allogeneic and 20 autologous) on 94 children (56 boys, median age 7.1 years) during 2006-2012. Patients suspected to have HHV6 or HHV7 infections were tested using polymerase chain reaction on serum and/or cerebrospinal fluid.Results: Among the 63 patients tested for HHV, 10 patients (15.9%) were infected (HHV-6 (n=6), HHV-7 (n=4)) at a median of 18 days post-HSCT (cumulative incidence 11.5% at 1 year). Manifestations included fever (90%), rash (70%), hepatitis (80%), pneumonitis (50%), central nervous system (CNS) manifestations (40%), and graft failure (10%). One patient had persistent CNS infection despite treatment with foscarnet, ganciclovir, and cidofovir. Seven patients cleared herpesvirus after a median of 22 days. Four patients died (relapse of malignancy [n=3], acute graft-versus-host disease [aGVHD] [n=1]). Herpesvirus infections were associated with adenovirus infection (p=0.001) and severe (grade III-IV) aGVHD (p=0.037).Conclusions: We concluded that HHV6 and HHV7 infections are common after pediatric HSCT. Most infections were self-limited and could be associated with adenovirus infection and severe aGVHD. Further studies are needed to evaluate predictors of severe morbidity or mortality, and define optimal prophylaxis and treatment.